Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al
- PMID: 32759253
- DOI: 10.1136/annrheumdis-2020-218176
Response to: 'Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus' by Kondo et al
Keywords: autoimmune diseases; hydroxychloroquine; lupus erythematosus; systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus.Ann Rheum Dis. 2021 May;80(5):e77. doi: 10.1136/annrheumdis-2020-218157. Epub 2020 Aug 5. Ann Rheum Dis. 2021. PMID: 32759254 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
